![]() TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies. | ![]() Secura Bio Secura Bio is an integrated biopharmaceutical company dedicated to the commercialization of oncology therapies. | ![]() Fusion Pharmaceuticals Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer. | ![]() Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. | ![]() Shoreline Biosciences Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms. | |
Founding Date | Founding Date 2018 | Founding Date 2019 | Founding Date 2014 | Founding Date 2018 | Founding Date 2020 |
Type | Type Public | Type Private | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations Waltham, US HQ | Locations Las Vegas, US HQ San Diego, US | Locations Hamilton, CA HQ Boston, US | Locations San Diego, US HQ Shanghai, CN Tokyo, JP | Locations San Diego, US HQ San Diego, US |
Employees | Employees 7316% increase | Employees 489% increase | Employees 101 | Employees 4 | Employees 4716% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) $10.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $2.1m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($129.8m) (FY, 2025) | Net income N/A | Net income ($94.9m) (FY, 2023) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 55m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 16m (about 7 years ago) | Latest funding round $ 43m (about 5 years ago) |
Total funding raised | Total funding raised $ 137.5m | Total funding raised $ 195m | Total funding raised $ 170.9m | Total funding raised $ 31m | Total funding raised $ 46m |

Secura Bio is an integrated biopharmaceutical company dedicated to the commercialization of oncology therapies.
View company
Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer.
View company
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
View company
Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms.
View company